30 closest matches · ranked by relevance
Catheter Infection · Catheter Thrombosis · Catheter Complications
Primary: Upper Extremity CR-UEVT — 7; 11 Participants
Infiltration of Peripheral IV Therapy
Primary: Time Infiltration Detected by Nurse — 29.8; 32.3 hours
IV Access
Primary: Number of Participants With Successful Cannulation of the Internal Jugular Vein — 34 Participants
Infiltration of Peripheral IV Therapy
Primary: Red Notification Sensitivity to Infiltrated Tissues — 96.4 percentage of infiltrations
Infiltration of Peripheral IV Therapy
Primary: Red Notification Sensitivity to Infiltrated Tissues — 99.0; 99.0 percentage of infiltrations detected
Obesity · Vascular Diseases
Primary: Successful First Attempt Peripheral Venous Cannulation — 96 participants
Intravenous Access
Primary: First Attempt Success Rate — 17; 11 Participants
Vascular Access Devices
Primary: IV Catheter Survival — 66; 55 Participants
Tourniquet
Primary: Peripheral IV Access Success Rate — 42; 43 Participants — p=0.95
Adult Patients With Peripherally Inserted Central Catheters
Primary: Rate of PICC Line Occlusions — 37 percentage of enrolled subjects
Pain · Local Anesthesia for Peripheral Intravenous Catheterization
Primary: Pain Score Following Anesthetic Administration — 2.81; 1.64; 2.05 units on a scale
Pain
Primary: Pain Difference Caused by PIVC (Peripheral Intravenous Catheter) Rated by NRS (Numeric Rating Scale) Between Application of 10% Licocaine Spray and Placebo-for the…
Infiltration of Peripheral IV Therapy
Primary: Normal Tissue Red Notification Rate — 0.24 red notifications per day
Infusion Site Injury
Primary: Percentage of PIVCs Sites With at Least One Clinical or Mechanical Complication (PIVC-related Complications) — 10; 6; 7 percentage of PIVC sites
PICC · Central Venous Catheter · Central Line
Primary: Participants With Complications With Central Access Including Insertion — 14; 10 Participants — p=0.271
Catheter Complications
Primary: Duration of IV Survival — 92; 136 hours
Intravenous Infiltration
Primary: Number of Participants With Intraveneous Infiltration of FDG During Routine PET/CT Imaging by Visually Assessment of Interpreting Physicians — 17; 32 Participants
Diabetes · Infection
Primary: Efficacy of Timentin Delivered by PILP Procedure (Treatment Group) Versus Intravenous Delivery (Control Group) at Reducing Microbiological Load in Subjects With…
Indication for Peripheral Intravenous Catheterisation
Primary: Patent Indwell Time Between PIVCs of Different Length and Gauge. — 40.19; 42.96; 35.91; 36.91 hours
Vascular Access Complications
Primary: First Attempt Success Rate With Peripheral IV (PIV) Catheter Placement — 84; 90 Participants
Vascular Access
Primary: Number of Participants With Success in the First Attempt — 56; 71; 53 Participants
Vascular Access Complication
Primary: First Attempt Success Rate With Peripheral IV Catheter Placement — 89; 47 percentage of participants — p=<0.0001
Vascular Access Complication
Primary: Percentage of Participants With Successfully Inserted Peripheral IV Catheter Placement on First Attempt — 85.3 percentage of participants
Pain, Acute · Anesthesia, Local · Trauma Injury
Primary: Average Pain Queried on First Postoperative Day — 3; 0.0 score on a scale — p=0.033
Dislodged Catheter · Catheter Related Complication
Primary: The Force (Newtons) Required to Dislodge an IV Catheter Secured in the Retrograde Direction. — 28.65; 15.41; 19.29 Newtons
Central Line Catheters
Primary: Adherence to Clinical Guidelines for Catheter Interventions and Management — 12; 0; 0; 11 # of catheter-related incidents
Obstruction; Catheter, Infusion Catheter (Vascular) · Catheter; Complications (Indwelling Catheter)
Primary: Number of Participants With First Complete Occlusion Within 1 Year — 5; 4 Participants
IV Catheter-Related Infection or Complication · Vascular Access Complication · Peripheral Venous Access
Primary: Blood Sampling Functionality — 70.19; 112.9 hours
Venous Thrombosis
Primary: Evidence of PICC-related Venous Thrombosis — 102; 95 Participants
Postoperative Pain
Primary: Number of Participants With and Without 30-Day Pain Medication Usage — 8; 6; 30; 36 participants